L Ding, N Wang, Q Wang, X Fan, Y Xin, S Wang - Cell Death Discovery, 2023 - nature.com
Sorafenib, a multiple-target tyrosine kinase inhibitor, is the standard of care for patients with
advanced hepatocellular carcinoma (HCC), but provides limited benefits. Emerging …